Today’s pharmaceuticals are remarkably advanced and powerful. Many diseases that were acute or fatal just a few decades ago can now be managed with the use of prescription medications.
However, these potent compounds and chemicals can also have a down side: they can have unintended effects in patients. In the rush to get new drugs into the marketplace, some pharmaceutical companies fail to perform the adequate safety tests or provide the necessary warning labels that would ensure the safety of new users. Profit becomes the motivating factor and patient health, integral to the longevity and success of a new drug, is compromised.
Our team is uniquely qualified to handle pharmaceutical cases. At other firms, lawyers learn about pharmaceuticals from nurse consultants, textbooks, and evening courses. At Kolsby Gordon, two of our lawyers are board-certified medical doctors who understand the language of medicine.
The attorneys at Kolsby Gordon are recognized as national leaders in achieving exceptional results for those who are injured by pharmaceuticals.
Dangerous Drugs & Pharmaceuticals Cases
High rate of heart disease among Fen-Phen users.
Patients used a combination of pharmaceuticals (phentermine and fenfluramine) in an effort to reduce appetite and manage obesity. Among those people, there was an extraordinarily high rate of a particular kind of heart disease. Kolsby Gordon attorneys represented many Fen-Phen victims with successful results.
Kolsby Gordon helped several individuals after they experienced specific cardiac problems, including a patient who required valve surgery to address heart disease brought on by the diet drug. Another patient, a young woman, discovered her primary pulmonary hypertension was related to diet drugs and turned to Kolsby Gordon to mount a convincing case. Both cases resulted in settlements of six-figures and higher.
DES causes cancer.
For decades, diethylstilbestrol (DES) was prescribed to pregnant women to prevent premature labor and miscarriage. Eventually it was linked to increased rates of cancer and other health problems among the millions of children born from the women who took DES. Kolsby Gordon handled the nation’s first DES case, and was appointed lead counsel for numerous follow-up lawsuits.
Baycol causes potentially fatal condition.
This statin drug was popular for lowering cholesterol. After it had been on the market for some time, it became clear that in some patients Baycol caused a condition where muscles deteriorated so badly that muscle cell contents was released into the bloodstream, where they could cause potentially fatal organ damage. Kolsby Gordon attorneys represented thousands of Baycol users in this successful national lawsuit.
